
Company Number
10654683
Next Accounts
Mar 2026
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
95 high street, beckenham, BR3 1AG
Website
-Pomanda estimates the enterprise value of PRIMARY OPHTHALMIC SOLUTIONS at £1.3m based on a Turnover of £2.5m and 0.53x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of PRIMARY OPHTHALMIC SOLUTIONS at £658.3k based on an EBITDA of £161.5k and a 4.08x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of PRIMARY OPHTHALMIC SOLUTIONS at £608.2k based on Net Assets of £258.9k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Primary Ophthalmic Solutions is a live company located in beckenham, BR3 1AG with a Companies House number of 10654683. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2017, it's largest shareholder is unknown. Primary Ophthalmic Solutions is a young, small sized company, Pomanda has estimated its turnover at £2.5m with healthy growth in recent years.
Pomanda's financial health check has awarded Primary Ophthalmic Solutions a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
3 Weak
Size
annual sales of £2.5m, make it larger than the average company (£682.6k)
- Primary Ophthalmic Solutions
£682.6k - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (8.1%)
- Primary Ophthalmic Solutions
8.1% - Industry AVG
Production
with a gross margin of 39.1%, this company has a comparable cost of product (39.1%)
- Primary Ophthalmic Solutions
39.1% - Industry AVG
Profitability
an operating margin of 6.4% make it as profitable than the average company (5.4%)
- Primary Ophthalmic Solutions
5.4% - Industry AVG
Employees
with 3 employees, this is below the industry average (17)
3 - Primary Ophthalmic Solutions
17 - Industry AVG
Pay Structure
on an average salary of £27.5k, the company has an equivalent pay structure (£27.5k)
- Primary Ophthalmic Solutions
£27.5k - Industry AVG
Efficiency
resulting in sales per employee of £823.9k, this is more efficient (£49.5k)
- Primary Ophthalmic Solutions
£49.5k - Industry AVG
Debtor Days
it gets paid by customers after 11 days, this is earlier than average (21 days)
- Primary Ophthalmic Solutions
21 days - Industry AVG
Creditor Days
its suppliers are paid after 182 days, this is slower than average (16 days)
- Primary Ophthalmic Solutions
16 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Primary Ophthalmic Solutions
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 46 weeks, this is less cash available to meet short term requirements (108 weeks)
46 weeks - Primary Ophthalmic Solutions
108 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.5%, this is a higher level of debt than the average (25.2%)
75.5% - Primary Ophthalmic Solutions
25.2% - Industry AVG
Primary Ophthalmic Solutions's latest turnover from June 2024 is estimated at £2.5 million and the company has net assets of £258.9 thousand. According to their latest financial statements, Primary Ophthalmic Solutions has 3 employees and maintains cash reserves of £707.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Turnover | |||||||
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | |||||||
Tax | |||||||
Profit After Tax | |||||||
Dividends Paid | |||||||
Retained Profit | |||||||
Employee Costs | |||||||
Number Of Employees | 3 | 3 | 1 | 2 | 1 | 2 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 10,105 | 8,843 | 8,569 | 11,425 | 15,233 | 15,970 | 2,910 |
Intangible Assets | |||||||
Investments & Other | |||||||
Debtors (Due After 1 year) | |||||||
Total Fixed Assets | 10,105 | 8,843 | 8,569 | 11,425 | 15,233 | 15,970 | 2,910 |
Stock & work in progress | |||||||
Trade Debtors | 75,769 | 145,158 | 157,374 | 175,051 | 106,241 | 94,431 | 48,045 |
Group Debtors | |||||||
Misc Debtors | 263,569 | 530,765 | 180,001 | 177,448 | 143,688 | ||
Cash | 707,887 | 8,912 | 101,119 | ||||
misc current assets | 64,297 | 29,147 | |||||
total current assets | 1,047,225 | 684,835 | 438,494 | 352,499 | 249,929 | 158,728 | 77,192 |
total assets | 1,057,330 | 693,678 | 447,063 | 363,924 | 265,162 | 174,698 | 80,102 |
Bank overdraft | |||||||
Bank loan | |||||||
Trade Creditors | 752,843 | 546,743 | 367,592 | 275,174 | 181,603 | 118,316 | 43,419 |
Group/Directors Accounts | |||||||
other short term finances | |||||||
hp & lease commitments | |||||||
other current liabilities | 45,583 | 20,720 | 5,145 | ||||
total current liabilities | 798,426 | 567,463 | 372,737 | 275,174 | 181,603 | 118,316 | 43,419 |
loans | |||||||
hp & lease commitments | |||||||
Accruals and Deferred Income | 13,353 | 15,219 | 3,300 | 24,903 | |||
other liabilities | |||||||
provisions | |||||||
total long term liabilities | 13,353 | 15,219 | 3,300 | 24,903 | |||
total liabilities | 798,426 | 567,463 | 372,737 | 288,527 | 196,822 | 121,616 | 68,322 |
net assets | 258,904 | 126,215 | 74,326 | 75,397 | 68,340 | 53,082 | 11,780 |
total shareholders funds | 258,904 | 126,215 | 74,326 | 75,397 | 68,340 | 53,082 | 11,780 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 3,368 | 2,948 | |||||
Amortisation | |||||||
Tax | |||||||
Stock | |||||||
Debtors | -336,585 | 338,548 | -15,124 | 102,570 | 155,498 | 46,386 | 48,045 |
Creditors | 206,100 | 179,151 | 92,418 | 93,571 | 63,287 | 74,897 | 43,419 |
Accruals and Deferred Income | 24,863 | 15,575 | -8,208 | -1,866 | 11,919 | -21,603 | 24,903 |
Deferred Taxes & Provisions | |||||||
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | |||||||
Change in Investments | |||||||
cash flow from investments | |||||||
Financing Activities | |||||||
Bank loans | |||||||
Group/Directors Accounts | |||||||
Other Short Term Loans | |||||||
Long term loans | |||||||
Hire Purchase and Lease Commitments | |||||||
other long term liabilities | |||||||
share issue | |||||||
interest | |||||||
cash flow from financing | |||||||
cash and cash equivalents | |||||||
cash | 698,975 | -92,207 | 101,119 | ||||
overdraft | |||||||
change in cash | 698,975 | -92,207 | 101,119 |
Perform a competitor analysis for primary ophthalmic solutions by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in BR3 area or any other competitors across 12 key performance metrics.
PRIMARY OPHTHALMIC SOLUTIONS group structure
Primary Ophthalmic Solutions has no subsidiary companies.
Ultimate parent company
PRIMARY OPHTHALMIC SOLUTIONS
10654683
Primary Ophthalmic Solutions currently has 4 directors. The longest serving directors include Mr Priteshkumar Patel (Mar 2017) and Mrs Uma-Devi Patel (Mar 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Priteshkumar Patel | 39 years | Mar 2017 | - | Director | |
Mrs Uma-Devi Patel | United Kingdom | 49 years | Mar 2017 | - | Director |
Mr Ketan Jadeja | England | 41 years | May 2022 | - | Director |
Mr Matthew Carter | England | 40 years | May 2024 | - | Director |
P&L
June 2024turnover
2.5m
+22%
operating profit
158.1k
0%
gross margin
39.1%
+0.81%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
258.9k
+1.05%
total assets
1.1m
+0.52%
cash
707.9k
+78.43%
net assets
Total assets minus all liabilities
company number
10654683
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
March 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
June 2024
previous names
N/A
accountant
-
auditor
-
address
95 high street, beckenham, BR3 1AG
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to primary ophthalmic solutions.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PRIMARY OPHTHALMIC SOLUTIONS. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|